Article
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
22 Mar 2013
Abstract excerpt
OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
